• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Fat Tail Daily

Investment Ideas From the Edge of the Bell Curve

  • Menu
    • Commodities
      • Resources and Mining
      • Copper
      • Gold
      • Iron Ore
      • Lithium
      • Silver
      • Graphite
      • Rare Earths
    • Technology
      • AI
      • Bitcoin
      • Cryptocurrency
      • Energy
      • Financial Technology
      • Bio Technology
    • Market Analysis
      • Latest ASX News
      • Dividend Shares
      • ETFs
      • Stocks and Bonds
    • Macro
      • Australian Economy
      • Central Banks
      • World Markets
    • Small Caps
    • More
      • Investment Guides
      • Premium Research
      • Editors
      • About
      • Contact Us
  • Latest
  • Fat Tail Series
  • About Us
Latest

Incannex Shares Swing Strongly as It Announces Agreement with Monash University

Like 0

By Ryan Clarkson-Ledward, Thursday, 03 March 2022

As energy continues to steal the market spotlight, Incannex Healthcare Ltd [ASX:IHL] is enduring a mixed day of trading.

As energy continues to steal the market spotlight, Incannex Healthcare Ltd [ASX:IHL] is enduring a mixed day of trading.

After flying out of the gates at the market open, up 5.5%, the share price has reversed. Now, at the time of writing, the stock is down 0.68% but climbing once more.

So what is behind this volatile trading day?

Well, Incannex has announced a new agreement with Monash University. One that will see this experimental healthcare company test the merits of psychedelic drugs and virtual reality to treat people…

An unusual type of therapy

If you’re unfamiliar with Incannex, then don’t confuse them with your average pharmaceutical company. Because what started out as a relatively ordinary pot stock, has quickly morphed into something much more.

Like I said, Incannex is now hoping to capitalise upon the emerging science of psychedelic treatment. Using an unspecified substance to try to treat patients with severe anxiety disorders.

What makes this agreement unique to what we’ve previously heard from the company is the addition of virtual reality, or VR, technology. Stimulus that management is clearly hoping will provide even greater therapeutic benefits than just the psychedelic medication alone.

The VR application that Incannex will be using in their investigation is known as BrainPark. A piece of software that was developed by Monash’s Turner Institute for Brain and Mental Health.

On top of this, the research being undertaken will be conducted by Monash as well. Dr Paul Liknaitzky, Head of the Turner Institute, will be leading the study. Overseeing the treatment process and potential of this highly experimental treatment.

In short, it is certainly an interesting endeavour, as CEO and managing director of Incannex, Joel Latham, notes:

‘We’re delighted to have commenced this exciting project and to have expanded our partnership with Monash. The combination of psychedelic compounds with an evidence-based VR therapy is a leading edge in the field of mental health treatments. We look forward to providing more detail about the project in due course when clinical trial planning has been finalised.’

What’s next for Incannex?

Needless to say, as with most research, the outcome will depend on the data.

For that reason, shareholders will no doubt be hoping for positive updates in future. After all, if this type of therapy shows any signs of breakthrough potential, it could be transformative.

However, given the nature of it too, it may certainly take some convincing. I’m sure plenty of traditional medical practitioners will be somewhat skeptical of these methods. Especially pairing two highly experimental concepts — psychedelics and VR — together.

Time will tell if Incannex has made the right move though…

One thing is for sure, early investors have enjoyed huge returns. Because Incannex doesn’t have a lot to show (yet), their potential has attracted a lot of interest. Something that is to be expected from such a forward-thinking business.

As such, it shows how savvy individuals can profit from merely prospective small caps. Something that our two exponential experts — Ryan Dinse and Izaac Ronay — are well aware of. Because when it comes to VR, they know that the sky is the limit.

Together, they’ve even prepared an entire deep dive into the metaverse.

A look at what is possible, what is coming, and how you could even profit from it. Check it out for yourself, in full, right here.

Because if thought psychedelics and VR is a crazy business idea, you’re only just scratching the surface…

Regards,

Ryan Clarkson-Ledward,
For Money Morning

All advice is general advice and has not taken into account your personal circumstances.

Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.

Ryan Clarkson-Ledward

Ryan’s Premium Subscriptions

Publication logo
Fat Tail Investment Research

Latest Articles

  • As Political Dumb-Wits Beat the Drums of War: Keep Commodities Front and Centre
    By James Cooper

    In today’s edition, James Cooper looks at the growing hostilities between Pakistan and India through the lens of the commodity cycle. And why it could matter more than most think.

  • The share market bears have no answer to this…
    By Callum Newman

    I came across a handy bit of info from Wilson Asset Management yesterday. Wilson says that there’s strong demand for Chinese assets despite the recent volatility and trade tensions. Why do we care? There could be profit in this.

  • The method in Trump’s tariff madness
    By Jim Rickards

    Trump is pursuing a twenty-first-century version of what was originally known as the American System. A system that made America great in the first place.

Primary Sidebar

Latest Articles

  • As Political Dumb-Wits Beat the Drums of War: Keep Commodities Front and Centre
  • The share market bears have no answer to this…
  • The method in Trump’s tariff madness
  • The first place to look thanks to the US/China truce
  • The trade war is over. Tax cut chaos is next.

Footer

Fat Tail Daily Logo
YouTube
Facebook
x (formally twitter)
LinkedIn

About

Investment ideas from the edge of the bell curve.

Go beyond conventional investing strategies with unique ideas and actionable opportunities. Our expert editors deliver conviction-led insights to guide your financial journey.

Quick Links

Subscribe

About

FAQ

Terms and Conditions

Financial Services Guide

Privacy Policy

Get in Touch

Contact Us

Email: support@fattail.com.au

Phone: 1300 667 481

All advice is general in nature and has not taken into account your personal circumstances. Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.

The value of any investment and the income derived from it can go down as well as up. Never invest more than you can afford to lose and keep in mind the ultimate risk is that you can lose whatever you’ve invested. While useful for detecting patterns, the past is not a guide to future performance. Some figures contained in our reports are forecasts and may not be a reliable indicator of future results. Any actual or potential gains in these reports may not include taxes, brokerage commissions, or associated fees.

Fat Tail Logo

Fat Tail Daily is brought to you by the team at Fat Tail Investment Research

Copyright © 2025 Fat Tail Daily | ACN: 117 765 009 / ABN: 33 117 765 009 / ASFL: 323 988